Breaking News Instant updates and real-time market news.

2020-11-17 16:31:00 CNHI CNH Industrial $10.38 / -0.08 (-0.76%) , PII Polaris $96.98 / +0.67 (+0.70%) 16:31 11/17/20 11/17 16:31 11/17/20 16:31	CNH Industrial names Scott W. Wine CEO CNH Industrial (CNHI) announced the appointment of Scott W. Wine as Chief Executive Officer, effective January 4, 2021. As a proven leader with considerable international experience across a variety of industries, Wine has a track record of producing exceptional results. Wine joins the company from Polaris Inc. (PII) where he was, since 2008, Chief Executive Officer and Chairman and CEO since 2013. CNHI CNH Industrial $10.38 / -0.08 (-0.76%) PII Polaris $96.98 / +0.67 (+0.70%)
CNHI PII CNHI CNH Industrial $10.38 / -0.08 (-0.76%) 11/11/20 BofA CNH Industrial upgraded to Buy from Neutral at BofA 11/11/20 BofA CNH Industrial upgraded to Buy from Neutral at BofA 11/06/20 Deutsche Bank CNH Industrial price target raised to $12 from $9 at Deutsche Bank 09/14/20 JPMorgan Core criticism of Nikola short report 'misconceived,' says JPMorgan PII Polaris $96.98 / +0.67 (+0.70%) 10/05/20 Fly Intel: Top five analyst upgrades 10/05/20 Baird Polaris upgraded to Outperform at Baird following pullback off highs 10/05/20 Baird Polaris upgraded to Outperform from Neutral at Baird 09/30/20 Fly Intel: Top five analyst upgrades

2020-11-17 16:31:00

CNHI

CNH Industrial

$10.38 / -0.08 (-0.76%)

, PII

Polaris

$96.98 / +0.67 (+0.70%)

16:31

11/17/20

11/17

16:31

11/17/20

16:31

CNH Industrial names Scott W. Wine CEO

CNH Industrial (CNHI) announced the appointment of Scott W. Wine as Chief Executive Officer, effective January 4, 2021. As a proven leader with considerable international experience across a variety of industries, Wine has a track record of producing exceptional results. Wine joins the company from Polaris Inc. (PII) where he was, since 2008, Chief Executive Officer and Chairman and CEO since 2013.

CNHI

CNH Industrial

$10.38 / -0.08 (-0.76%)

PII

Polaris

$96.98 / +0.67 (+0.70%)

CNHI
PII

CNHI CNH Industrial

$10.38 / -0.08 (-0.76%)

11/11/20 BofA: CNH Industrial upgraded to Buy from Neutral at BofA

11/11/20 BofA: CNH Industrial upgraded to Buy from Neutral at BofA

11/06/20 Deutsche Bank: CNH Industrial price target raised to $12 from $9 at Deutsche Bank

09/14/20 JPMorgan: Core criticism of Nikola short report 'misconceived,' says JPMorgan

PII Polaris

$96.98 / +0.67 (+0.70%)

10/05/20: Fly Intel: Top five analyst upgrades

10/05/20 Baird: Polaris upgraded to Outperform at Baird following pullback off highs

10/05/20 Baird: Polaris upgraded to Outperform from Neutral at Baird

09/30/20: Fly Intel: Top five analyst upgrades

TODAY'S FREE FLY STORIES

Syndicate	NetApp files automatic mixed securities shelf 16:59 03/01/21 03/01 16:59 03/01/21 16:59 NTAP NetApp $65.22 / +2.63 (+4.20%) ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options NTAP NetApp $65.22 / +2.63 (+4.20%) 02/24/21 NetApp falls over 9% to $65 per share after Q3 results, Q4 guidance 01/12/21 Cigna appoints George Kurian to Board of Directors 12/21/20 NetApp CFI Michael Berry purchases almost $1M in company shares 12/01/20 NetApp jumps 3% to $55.94 after Q2 earnings beat, above-consensus Q3 guidance NTAP NetApp $65.22 / +2.63 (+4.20%) 02/26/21 Daiwa NetApp upgraded to Outperform from Neutral at Daiwa 02/25/21 Wedbush NetApp price target raised to $70 from $62 at Wedbush 02/25/21 Wells Fargo NetApp price target raised to $65 from $60 at Wells Fargo 02/25/21 Credit Suisse NetApp price target raised to $80 from $75 at Credit Suisse NTAP NetApp $65.22 / +2.63 (+4.20%) 02/24/21 NetApp sees Q4 adjusted EPS $1.06-$1.14, consensus $1.09 02/24/21 NetApp reports Q3 adjusted EPS $1.10, consensus $1.01 02/24/21 Notable companies reporting after market close 12/01/20 NetApp sees Q3 EPS 94c-$1.02, consensus 89c NTAP NetApp $65.22 / +2.63 (+4.20%) 02/24/21 Fly Intel: After-Hours Movers 12/02/20 Fly Intel: Wall Street's top stories for Wednesday 12/02/20 Fly Intel: Wall Street's top stories at midday 12/02/20 Fly Intel: Pre-market Movers 05/27/21 NetApp - NTAP NTAP NetApp $65.22 / +2.63 (+4.20%) 12/22/20 Early notable gainers among liquid option names on December 22nd 12/16/20 Early notable gainers among liquid option names on December 16th 12/02/20 Early notable gainers among liquid option names on December 2nd
Hot Stocks	Genuine Parts appoints Napoleon Rutledge as chief accounting officer » 16:59 03/01/21 03/01 16:59 03/01/21 16:59 GPC Genuine Parts $108.29 / +2.93 (+2.78%) Genuine Parts announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly GPC Genuine Parts $108.29 / +2.93 (+2.78%) 02/17/21 Genuine Parts sees FY21 net cash from operating activities $1B-$1.2B 02/17/21 Genuine Parts reports Q4 SSS down 2.8% 02/16/21 Genuine Parts appoints Juliette Pryor as independent director 01/14/21 Genuine Parts names Will Stengel president GPC Genuine Parts $108.29 / +2.93 (+2.78%) 02/18/21 RBC Capital Genuine Parts price target raised to $104 from $97 at RBC Capital 12/02/20 Fly Intel: Top five analyst downgrades 12/02/20 BofA Genuine Parts double downgraded to Underperform after doubling at BofA 12/02/20 BofA Genuine Parts downgraded to Underperform from Buy at BofA GPC Genuine Parts $108.29 / +2.93 (+2.78%) 02/17/21 Genuine Parts sees FY21 diluted EPS $5.55-$5.75, consensus $5.76 02/17/21 Genuine Parts reports Q4 adjusted EPS $1.52, consensus $1.35 02/16/21 Notable companies reporting before tomorrow's open 02/16/21 Notable companies reporting before tomorrow's open GPC Genuine Parts $108.29 / +2.93 (+2.78%) 12/10/20 Goldman Sachs says buy Floor & Decor, sell Best Buy
Upgrade	Altair upgraded to Neutral from Sell at Goldman Sachs » 16:57 03/01/21 03/01 16:57 03/01/21 16:57 ALTR Altair $63.27 / +1.72 (+2.79%) Goldman Sachs analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly ALTR Altair $63.27 / +1.72 (+2.79%) 02/24/21 Altair acquires Flow Simulator sofftware from GE Aviation 01/19/21 Altair signs MoU with Rolls-Royce Germany 01/05/21 Toggled, Yorkland Controls collaborate for intelligent lighting solutions 12/08/20 Altair CFO Howard Morof to step down, Matthew Brown to succeed ALTR Altair $63.27 / +1.72 (+2.79%) 02/19/21 RBC Capital Altair price target raised to $58 from $49 at RBC Capital 12/09/20 JPMorgan Altair upgraded to Overweight from Neutral at JPMorgan 12/08/20 Benchmark Altair price target raised to $60 from $53 at Benchmark 11/09/20 RBC Capital Altair price target raised to $49 from $42 at RBC Capital ALTR Altair $63.27 / +1.72 (+2.79%) 02/25/21 Altair sees FY21 revenue $423M-$431M, consensus $486.22M 02/25/21 Altair sees Q1 revenue $138M-$140M, consensus $134.72M 02/25/21 Altair reports Q4 EPS 17c, consensus 0c 12/08/20 Altair reaffirms Q4, FY20 guidance ALTR Altair $63.27 / +1.72 (+2.79%) 02/22/21 Fly Insider: Corvus, ALJ Regional Holdings among week's notable insider trades 12/09/20 JPMorgan downgrades Zoom, upgrades Autodesk in software ratings shakeup
Syndicate	RedHill Biopharma announces $10M bought deal offering of ADSs » 16:55 03/01/21 03/01 16:55 03/01/21 16:55 RDHL RedHill Biopharma $9.19 / -0.33 (-3.47%) RedHill Biopharma… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings RDHL RedHill Biopharma $9.19 / -0.33 (-3.47%) 02/23/21 RedHill Biopharma to expand opaganib global Phase 2/3 COVID-19 study 01/29/21 RedHill Biopharma announces independent DSMB recommendation for opaganib 01/06/21 RedHill Biopharma's RHB-204 granted FDA Fast Track designation for NTM disease 12/31/20 RedHill Biopharma announces safety, efficacy data from Phase 2 COVID-19 study RDHL RedHill Biopharma $9.19 / -0.33 (-3.47%) 11/12/20 Roth Capital RedHill Biopharma price target lowered to $12 from $16 at Roth Capital 09/11/20 BTIG RedHill Biopharma initiated with a Buy at BTIG 08/14/20 Roth Capital Roth Capital maintains Buy on RedHill after 'noisy' quarter 07/07/20 SMBC Nikko RedHill Biopharma initiated with an Outperform at SMBC Nikko RDHL RedHill Biopharma $9.19 / -0.33 (-3.47%) 11/12/20 RedHill Biopharma reports Q3 EPS (5c), consenus (16c)
Syndicate	Yum China files to sell 2.1M shares of common stock 16:53 03/01/21 03/01 16:53 03/01/21 16:53 YUMC Yum China $59.87 / +0.095 (+0.16%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly YUMC Yum China $59.87 / +0.095 (+0.16%) 02/05/21 Yum China named official supplier of Asian Games Hangzhou 2022 02/03/21 Yum China sees 'significant headwinds' in Q1 02/03/21 Yum China reports Q4 restaurant margin 15.1% vs. 12.4% a year ago 02/03/21 Yum China sees FY21 CapEx approximately $600M YUMC Yum China $59.87 / +0.095 (+0.16%) 01/26/21 Jefferies Yum China price target raised to $68.70 from $63.10 at Jefferies 11/02/20 Citi Yum China price target raised to $71.30 from $60.15 at Citi 09/10/20 Goldman Sachs Yum China H-shares initiated with a Conviction Buy at Goldman Sachs 09/10/20 Goldman Sachs Yum China H-shares initiated with a Conviction Buy at Goldman Sachs YUMC Yum China $59.87 / +0.095 (+0.16%) 02/03/21 Yum China reports Q4 adjusted EPS 35, consensus 26c 10/28/20 Yum China reports Q3 adjusted EPS 66c, consensus 49c 10/28/20 Notable companies reporting after market close 04 Sep YUMC Yum China $59.87 / +0.095 (+0.16%) 09/04/20 Yum China to raise more than $2B in Hong Kong listing, FT reports YUMC Yum China $59.87 / +0.095 (+0.16%) 02/03/21 Fly Intel: After-Hours Movers 09/10/20 Fly Intel: Pre-market Movers

Earnings	AppFolio reports Q4 EPS (1c), consensus 7c » 16:52 03/01/21 03/01 16:52 03/01/21 16:52 APPF AppFolio $160.72 / -4.985 (-3.01%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events APPF AppFolio $160.72 / -4.985 (-3.01%) 09/08/20 AppFolio sells MyCase to Apax Partners fund for $193M APPF AppFolio $160.72 / -4.985 (-3.01%) 02/25/21 DA Davidson AppFolio price target raised to $126 from $110 at DA Davidson 01/25/21 Stephens AppFolio initiated with an Underweight at Stephens 01/25/21 Stephens AppFolio initiated with an Underweight at Stephens 10/26/20 Keefe Bruyette AppFolio initiated with a Market Perform at Keefe Bruyette APPF AppFolio $160.72 / -4.985 (-3.01%) 11/09/20 AppFolio reports Q3 EPS $3.86 vs. 14c last year 16:30 Today AppFolio - APPF
Earnings	Adverum Biotechnologies reports Q4 EPS (39c), consensus (32c) » 16:50 03/01/21 03/01 16:50 03/01/21 16:50 ADVM Adverum Biotechnologies $13.29 / +0.44 (+3.42%) Cash, cash equivalents… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events ADVM Adverum Biotechnologies $13.29 / +0.44 (+3.42%) 16:47 Today Adverum Biotechnologies provides update on ADVM-022 clinical development path 02/22/21 Adverum appoints Reed Tuckson to board of directors 02/02/21 Adverum announces publication of safety data on ADVM-022 gene therapy 01/11/21 Adverum Biotechnologies announces 2021 focus areas ADVM Adverum Biotechnologies $13.29 / +0.44 (+3.42%) 12/15/20 UBS Adverum Biotechnologies initiated with a Neutral at UBS 11/15/20 Piper Sandler Adverum Biotechnologies shares should grind higher over time, says Piper Sandler 11/12/20 Raymond James Adverum Biotechnologies upgraded to Market Perform from Underperform at Raymond James 11/12/20 Raymond James Adverum Biotechnologies upgraded to Market Perform at Raymond James ADVM Adverum Biotechnologies $13.29 / +0.44 (+3.42%) 11/05/20 Adverum Biotechnologies reports Q3 EPS (31c), consensus (34c) 13 Aug 03/08/21 Biopharmaceuticals 16:30 Today Adverum Biotechnologies - ADVM
Hot Stocks	Adverum Biotechnologies provides update on ADVM-022 clinical development path » 16:47 03/01/21 03/01 16:47 03/01/21 16:47 ADVM Adverum Biotechnologies $13.29 / +0.44 (+3.42%) Adverum Biotechnologies… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events ADVM Adverum Biotechnologies $13.29 / +0.44 (+3.42%) 02/22/21 Adverum appoints Reed Tuckson to board of directors 02/02/21 Adverum announces publication of safety data on ADVM-022 gene therapy 01/11/21 Adverum Biotechnologies announces 2021 focus areas 01/11/21 Adverum Biotechnologies completes patient enrollment for INFINITY Phase 2 trial ADVM Adverum Biotechnologies $13.29 / +0.44 (+3.42%) 12/15/20 UBS Adverum Biotechnologies initiated with a Neutral at UBS 11/15/20 Piper Sandler Adverum Biotechnologies shares should grind higher over time, says Piper Sandler 11/12/20 Raymond James Adverum Biotechnologies upgraded to Market Perform from Underperform at Raymond James 11/12/20 Raymond James Adverum Biotechnologies upgraded to Market Perform at Raymond James ADVM Adverum Biotechnologies $13.29 / +0.44 (+3.42%) 11/05/20 Adverum Biotechnologies reports Q3 EPS (31c), consensus (34c) 13 Aug 03/08/21 Biopharmaceuticals 16:30 Today Adverum Biotechnologies - ADVM
On The Fly	Fly Intel: Wall Street's top stories for Monday » 16:45 03/01/21 03/01 16:45 03/01/21 16:45 JNJ Johnson & Johnson $159.34 / +0.92 (+0.58%) , XOM Exxon Mobil $56.40 / +2.02 (+3.71%) , OTRK Ontrak $31.62 / -27.515 (-46.53%) , ATNX Athenex $5.47 / -6.715 (-55.11%) , DKNG DraftKings $68.71 / +7.24 (+11.78%) , MORF Morphic $84.57 / +48.64 (+135.37%) The three major averages… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options JNJ XOM OTRK ATNX DKNG MORF JNJ Johnson & Johnson $159.34 / +0.92 (+0.58%) 02/28/21 Fly Intel: Top five weekend stock stories 02/28/21 CDC Advisory Committee recommends J&J single-shot COVID vaccine for adults 18+ 02/27/21 Johnson & Johnson Covid vaccine granted emergency approval from FDA 02/26/21 J&J confirms FDA panel recommends COVID-19 vaccine for EUA XOM Exxon Mobil $56.40 / +2.02 (+3.71%) 08:47 Today Michael Angelakis and Jeffrey Ubben join ExxonMobil board 02/24/21 Exxon Mobil to sell U.K. upstream central and northern North Sea assets 02/16/21 Paulson & Co. buys Exxon, exits Qiagen in Q4 02/12/21 Exxon Mobil targets cash operating expense reduction of $6B by FY23 OTRK Ontrak $31.62 / -27.515 (-46.53%) 10/29/20 Ontrak acquires behavior change platform LifeDojo 10/13/20 Ontrak rises after announcing launch of Ontrak-CI program ATNX Athenex $5.47 / -6.715 (-55.11%) 07:35 Today Athenex trading resumes 07:22 Today Athenex expects cash to fund operations into 2Q22 07:21 Today Athenex announces key anticipated future milestones 07:08 Today FDA requests new study from Athenex for oral paclitaxel plus encequidar DKNG DraftKings $68.71 / +7.24 (+11.78%) 02/26/21 DraftKings MUPs for B2C segment up 44% vs. 4Q19 02/25/21 Bill introduced in Florida Senate to authorize sports wagering 02/25/21 Nevada reports January statewide gaming win down 26.6% to $761.85M 02/25/21 DraftKings names Cal Ripken Jr. as special advisor to board of directors MORF Morphic $84.57 / +48.64 (+135.37%) 09:52 Today Morphic Holding Inc trading resumes 09:47 Today Morphic Holding Inc trading halted, volatility trading pause 07:26 Today Morphic Holding reports interim results from Phase 1 trial of MORF-057 01/05/21 Morphic Therapeutic expands R&D collaboration with Janssen JNJ XOM OTRK ATNX DKNG MORF JNJ Johnson & Johnson $159.34 / +0.92 (+0.58%) 02/10/21 BTIG Model N upgraded to Buy from Neutral at BTIG 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 02/01/21 Wells Fargo Moderna price target raised to $145 from $129 at Wells Fargo 02/01/21 BofA BofA downgrades Moderna to Underperform, sees shares priced for 'best-case' XOM Exxon Mobil $56.40 / +2.02 (+3.71%) 02/26/21 Barclays Exxon Mobil price target raised to $65 from $59 at Barclays 02/16/21 Credit Suisse Exxon Mobil price target raised to $62 from $52 at Credit Suisse 02/08/21 Fly Intel: Top five analyst upgrades 02/08/21 Exane BNP Paribas Exxon Mobil upgraded to Neutral from Underperform at Exane BNP Paribas OTRK Ontrak $31.62 / -27.515 (-46.53%) 10:21 Today RBC Capital RBC downgrades Ontrak to Sector Perform, cuts target to $32 after loss of Aetna 10:17 Today RBC Capital Ontrak downgraded to Sector Perform from Outperform at RBC Capital 01/05/21 Benchmark GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021 01/04/21 B. Riley Securities Ontrak price target raised to $110 from $100 at B. Riley Securities ATNX Athenex $5.47 / -6.715 (-55.11%) 16:38 Today JPMorgan JPMorgan downgrades Athenex on 'huge surprise' from FDA 16:31 Today SVB Leerink Athenex downgraded to Market Perform from Outperform at SVB Leerink 16:27 Today JPMorgan Athenex downgraded to Neutral from Overweight at JPMorgan 13:53 Today Laidlaw Athenex price target lowered to $13 from $38 at Laidlaw DKNG DraftKings $68.71 / +7.24 (+11.78%) 09:18 Today Craig-Hallum DraftKings price target raised to $70 from $65 at Craig-Hallum 09:09 Today Canaccord DraftKings price target raised to $80 from $65 at Canaccord 08:39 Today Northland DraftKings price target raised to $70 from $55 at Northland 07:05 Today Benchmark DraftKings price target raised to $69 from $66 at Benchmark MORF Morphic $84.57 / +48.64 (+135.37%) 12:48 Today Wells Fargo Morphic Holding price target raised to $103 from $40 at Wells Fargo 02/02/21 RBC Capital Morphic Holding price target raised to $50 from $35 at RBC Capital 10/26/20 RBC Capital Morphic Holding initiated with an Outperform at RBC Capital 08/11/20 BMO Capital Morphic Holding price target raised to $37 from $30 at BMO Capital JNJ XOM OTRK ATNX DKNG MORF JNJ Johnson & Johnson $159.34 / +0.92 (+0.58%) 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open 01/25/21 Notable companies reporting before tomorrow's open XOM Exxon Mobil $56.40 / +2.02 (+3.71%) 02/02/21 Exxon Mobil reports Q4 ex-items EPS 3c, consensus 1c 02/01/21 Notable companies reporting before tomorrow's open 02/01/21 Notable companies reporting before tomorrow's open 12/30/20 Exxon Mobil says Q4 income boosted by up to $600M from gas prices OTRK Ontrak $31.62 / -27.515 (-46.53%) 08:07 Today Ontrak sees FY21 revenue $100M, consensus $165.05M 08:06 Today Ontrak reports Q4 EPS (7c), consensus (30c) 11/05/20 Ontrak reports Q3 EPS (36c), consensus (35c) ATNX Athenex $5.47 / -6.715 (-55.11%) 07:21 Today Athenex reports Q4 adjusted EPS (43c), consensus (44c) 11/05/20 Athenex sees 2020 y-o-y product sales growth in low twenties percentage growth 11/05/20 Athenex reports Q3 EPS (44c), consensus (43c) DKNG DraftKings $68.71 / +7.24 (+11.78%) 02/26/21 DraftKings raises 2021 revenue view to $900M-$1B from $750M-$850M 02/26/21 DraftKings reports Q4 revenue $322M, consensus $232.6M 02/25/21 Notable companies reporting before tomorrow's open 02/25/21 Notable companies reporting before tomorrow's open MORF Morphic $84.57 / +48.64 (+135.37%) 12:53 Today Morphic Holding reports 2020 EPS ($1.47), consensus ($1.41) 11/09/20 Morphic Holding reports Q3 EPS 17c, consensus (48c) 07 Oct 10 Sep 19 Jun JNJ XOM DKNG JNJ Johnson & Johnson $159.34 / +0.92 (+0.58%) 02/26/21 FDA panel says J&J COVID-19 vaccine benefits outweigh risks, CNBC says 02/26/21 FDA advisory panel to review J&J's Covid-19 vaccine Friday, WSJ reports 02/25/21 Johnson & Johnson one-dose COVID-19 vaccine approved by Bahrain, Reuters says 02/24/21 FDA to release detailed review of J&J's Covid vaccine, WSJ reports XOM Exxon Mobil $56.40 / +2.02 (+3.71%) 08:22 Today Ubben, Angelakis to join board of Exxon Mobil, CNBC reports 02/17/21 Texas prohibits natgas firms from taking fuel out of state, Bloomberg says 02/17/21 Saudis to raise oil output as prices recover, WSJ reports 02/05/21 Exxon considering nominating Jeff Ubben to board, CNBC reports DKNG DraftKings $68.71 / +7.24 (+11.78%) 02/12/21 Nevada to roll back capacity restrictions on casinos, Reno Gazette Journal says 02/09/21 TX Lt. Gov. sees no support for legalized sports betting, Houston Chronicle says 01/28/21 DraftKings to bring sportsbook, casino apps to Google Play, 9to5Google says 01/28/21 DraftKings sportsbook, casino apps soon available via Google Play, Reuters says JNJ XOM OTRK ATNX DKNG MORF JNJ Johnson & Johnson $159.34 / +0.92 (+0.58%) 12:23 Today Fly Intel: Wall Street's top stories at midday 09:15 Today Fly Intel: Pre-market Movers 02/24/21 Fly Intel: Wall Street's top stories for Wednesday 02/24/21 Fly Intel: Wall Street's top stories at midday XOM Exxon Mobil $56.40 / +2.02 (+3.71%) 12:23 Today Fly Intel: Wall Street's top stories at midday 09:15 Today Fly Intel: Pre-market Movers 02/02/21 Fly Intel: Wall Street's top stories for Tuesday 02/02/21 Fly Intel: Wall Street's top stories at midday OTRK Ontrak $31.62 / -27.515 (-46.53%) 12:23 Today Fly Intel: Wall Street's top stories at midday 11:12 Today Ontrak plunges after announcing loss of Aetna contract ATNX Athenex $5.47 / -6.715 (-55.11%) 12:23 Today Fly Intel: Wall Street's top stories at midday 09:15 Today Fly Intel: Pre-market Movers 12/15/20 Fly Intel: Pre-market Movers 09/21/20 Fly Insider: Kingsway Financial, Nvidia among week's notable insider trades DKNG DraftKings $68.71 / +7.24 (+11.78%) 02/26/21 Fly Intel: Wall Street's top stories for Friday 02/26/21 Bet On It: Florida and Texas trying to get in on the action 02/26/21 Fly Intel: Wall Street's top stories at midday 02/26/21 Fly Intel: Pre-market Movers MORF Morphic $84.57 / +48.64 (+135.37%) 12:23 Today Fly Intel: Wall Street's top stories at midday 03/05/21 Medical Technology 03/08/21 Biopharmaceuticals 00:00 Today 26th Annual Energy Virtual Summit 03/02/21 41st Annual Healthcare Virtual Conference 08:00 Today Athenex - ATNX 08:00 Today Morphic Holding - MORF 03/09/21 Ontrak - OTRK 04/20/21 Johnson & Johnson - JNJ 03/03/21 Exxon Mobil Corp. 03/09/21 DraftKings Inc JNJ XOM OTRK DKNG JNJ Johnson & Johnson $159.34 / +0.92 (+0.58%) 09:40 Today Unusually active option classes on open March 1st 01/26/21 Early notable gainers among liquid option names on January 26th 12/01/20 Johnson & Johnson call volume above normal and directionally bullish 10/13/20 Unusually active option classes on open October 13th XOM Exxon Mobil $56.40 / +2.02 (+3.71%) 09:40 Today Unusually active option classes on open March 1st 02/09/21 Unusually active option classes on open February 9th 02/08/21 Exxon Mobil call volume above normal and directionally bullish 02/08/21 Unusually active option classes on open February 8th OTRK Ontrak $31.62 / -27.515 (-46.53%) 10/12/20 Largest borrow rate increases among liquid names 09/16/20 Ontrak put volume heavy and directionally bearish 09/15/20 Ontrak put volume heavy and directionally bearish DKNG DraftKings $68.71 / +7.24 (+11.78%) 02/02/21 DraftKings call volume above normal and directionally bullish 01/27/21 DraftKings call volume above normal and directionally bullish 01/26/21 DraftKings call volume above normal and directionally bullish 01/12/21 DraftKings call volume above normal and directionally bullish
Hot Stocks	Ormat Technologies calls Hindenburg Research comments 'misleading' » 16:44 03/01/21 03/01 16:44 03/01/21 16:44 ORA Ormat Technologies $84.64 / -0.96 (-1.12%) The company states:… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly ORA Ormat Technologies $84.64 / -0.96 (-1.12%) 02/24/21 Ormat Technologies increases quarterly dividend by 9% to 12c per share 11/12/20 Ormat Technologies resumes operation of Puna Geothermal Power Plant 10/01/20 Ormat Technologies expands energy storage footprint in California 09/23/20 Ormat Technologies VP Krieger buys 3,000 shares of company stock ORA Ormat Technologies $84.64 / -0.96 (-1.12%) 02/02/21 Roth Capital Ormat Technologies price target raised to $100 from $70 at Roth Capital 01/20/21 JPMorgan Ormat Technologies price target raised to $94 from $86 at JPMorgan 01/06/21 JPMorgan Ormat downgraded to Neutral on valuation at JPMorgan 01/06/21 JPMorgan Ormat Technologies downgraded to Neutral from Overweight at JPMorgan ORA Ormat Technologies $84.64 / -0.96 (-1.12%) 02/24/21 Ormat Technologies sees FY21 revenue $640M-$675M, consensus $707.04M 02/24/21 Ormat Technologies reports Q4 adjusted EPS 39c, consensus 34c 11/03/20 Ormat cuts FY20 revenue view to $707M-$717M from $710M-$725M 11/03/20 Ormat Technologies reports Q3 EPS 31c, consensus 27c 19 Nov ORA Ormat Technologies $84.64 / -0.96 (-1.12%) 11/16/20 Fly Intel: After-Hours Movers 11/03/20 Fly Intel: After-Hours Movers

Syndicate	Knoll files to sell 10.68M shares of common stock for holders 16:44 03/01/21 03/01 16:44 03/01/21 16:44 KNL Knoll $16.99 / +0.59 (+3.60%) ShowHide Related Items >><< Company News Earnings KNL Knoll $16.99 / +0.59 (+3.60%) 10/27/20 Knoll falls -13.1% 10/16/20 Knoll appoints Jeffrey Henderson to board of directors 09/17/20 Furniture makers jump after Herman Miller earnings helped by 'home office' trend 09/17/20 Knoll rises 15.8% KNL Knoll $16.99 / +0.59 (+3.60%) 02/10/21 Knoll reports Q4 EPS 14c, consensus 27c
Hot Stocks	Bottomline Technologies Bottomline appoints Bruce Bowden CFO » 16:43 03/01/21 03/01 16:43 03/01/21 16:43 EPAY Bottomline Technologies $44.39 / -0.44 (-0.98%) Bottomline announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings On The Fly EPAY Bottomline Technologies $44.39 / -0.44 (-0.98%) 08/07/20 RBC Capital Bottomline Technologies price target raised to $57 from $51 at RBC Capital 05/19/20 Citi Bottomline Technologies price target raised to $49 from $46 at Citi 05/08/20 Raymond James Bottomline Technologies price target lowered to $51 from $66 at Raymond James 05/07/20 Craig-Hallum Bottomline Technologies price target lowered to $53 from $68 at Craig-Hallum EPAY Bottomline Technologies $44.39 / -0.44 (-0.98%) 02/02/21 Bottomline Technologies sees FY21 EPS $1.13-$1.17, consensus $1.21 02/02/21 Bottomline Technologies sees Q3 EPS 25c-27c, consensus 30c 02/02/21 Bottomline Technologies reports Q2 EPS 30c, consensus 28c 11/05/20 Bottomline Technologies sees Q2 EPS 27c-28c, consensus 31c EPAY Bottomline Technologies $44.39 / -0.44 (-0.98%) 11/05/20 Fly Intel: After-Hours Movers
Earnings	Idera Pharmaceuticals reports Q4 ex-items EPS (22c), consensus (23c) » 16:42 03/01/21 03/01 16:42 03/01/21 16:42 IDRA Idera Pharmaceuticals $4.90 / +0.55 (+12.64%) As of December 31, 2020,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings IDRA Idera Pharmaceuticals $4.90 / +0.55 (+12.64%) 11/17/20 Idera Pharmaceuticals appoints Dan Soland COO 09/28/20 Idera Pharmaceuticals announces patent coverage for tilsotolimod 09/15/20 Idera Pharmaceuticals to present tilsotolimod data at ESMO Virtual Congress IDRA Idera Pharmaceuticals $4.90 / +0.55 (+12.64%) 11/02/20 JPMorgan Idera Pharmaceuticals assumed with an Overweight at JPMorgan 09/01/20 Jefferies Checkmate Pharmaceuticals initiated with a Buy at Jefferies IDRA Idera Pharmaceuticals $4.90 / +0.55 (+12.64%) 10/29/20 Idera Pharmaceuticals reports Q3 EPS (59c), consensus (22c)
Conference/Events	UBS technology analyst to hold an analyst/industry conference call » 16:42 03/01/21 03/01 16:42 03/01/21 16:42 Technology Analyst Arcuri… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Syndicate	BioCryst files automatic mixed securities shelf 16:42 03/01/21 03/01 16:42 03/01/21 16:42 BCRX BioCryst $11.97 / +1.175 (+10.88%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options BCRX BioCryst $11.97 / +1.175 (+10.88%) 02/25/21 BioCryst not providing specific revenue or operating expense guidance 02/03/21 BioCryst announces FDA approval of supplemental NDA for RAPIVAB 02/02/21 BioCryst reports inducement grants under Nasdaq listing rule 02/01/21 BioCryst jumps after WallStreetBets user says 'most undervalued' in market BCRX BioCryst $11.97 / +1.175 (+10.88%) 07:37 Today Cowen Cowen starts BioCryst at Outperform with $16 price target 07:03 Today Cowen BioCryst initiated with an Outperform at Cowen 02/26/21 Barclays BioCryst price target raised to $13 from $9 at Barclays 02/25/21 Piper Sandler BioCryst's U.S. launch of Orladeyo now underway, says Piper Sandler BCRX BioCryst $11.97 / +1.175 (+10.88%) 02/25/21 BioCryst reports Q4 EPS (34c), consensus (25c) 11/05/20 BioCryst reports Q3 EPS (26c), consensus (25c) 28 May BCRX BioCryst $11.97 / +1.175 (+10.88%) 02/01/21 WallStreetBets tells CBS 'large amount' of stock content coming from bots BCRX BioCryst $11.97 / +1.175 (+10.88%) 01/25/21 Fly Intel: After-Hours Movers 12/04/20 Fly Intel: Pre-market Movers 10/22/20 Fly Intel: Pre-market Movers 09/30/20 Fly Intel: Wall Street's top stories for Wednesday 03/02/21 41st Annual Healthcare Virtual Conference BCRX BioCryst $11.97 / +1.175 (+10.88%) 02/19/21 BioCryst call volume above normal and directionally bullish 02/12/21 BioCryst call volume above normal and directionally bullish 01/15/21 BioCryst call volume above normal and directionally bullish 12/04/20 Unusually active option classes on open December 4th

Syndicate	Gamida Cell files to sell 6.33M ordinary shares for holders 16:41 03/01/21 03/01 16:41 03/01/21 16:41 GMDA Gamida Cell $9.86 / +0.46 (+4.89%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options GMDA Gamida Cell $9.86 / +0.46 (+4.89%) 02/09/21 Gamida Cell says phase 3 results show faster hematopoietic recovery 01/11/21 Gamida Cell to present full data from Phase 3 study of omidubicel at TCT meeting 12/14/20 FDA asks Gamida Cell for more manufacturing-related data for pre-BLA 12/09/20 Gamida Cell provides achieves all three secondary endpoints of omidubicel study GMDA Gamida Cell $9.86 / +0.46 (+4.89%) 02/10/21 H.C. Wainwright Gamida Cell price target raised to $27 from $15 at H.C. Wainwright 02/09/21 Piper Sandler Gamida Cell price target raised to $25 from $13 at Piper Sandler 12/14/20 Oppenheimer Gamida Cell price target lowered to $17 from $20 at Oppenheimer 12/14/20 Piper Sandler Gamida Cell delay does not impact peak sales, says Piper Sandler GMDA Gamida Cell $9.86 / +0.46 (+4.89%) 11/10/20 Gamida Cell reports Q3 EPS (30c), consensus (31c) 19 May GMDA Gamida Cell $9.86 / +0.46 (+4.89%) 02/10/21 Fly Intel: Wall Street's top stories for Wednesday 02/10/21 Fly Intel: Wall Street's top stories at midday 02/10/21 Fly Intel: Pre-market Movers 12/07/20 Fly Intel: Wall Street's top stories for Monday GMDA Gamida Cell $9.86 / +0.46 (+4.89%) 01/19/21 Nine new option listings and thirteen option delistings on January 19th
Earnings	Aziyo Biologics sees FY21 revenue $50M-$52M, consensus $50.81M » 16:41 03/01/21 03/01 16:41 03/01/21 16:41 AZYO Aziyo Biologics $15.26 / -0.205 (-1.33%) "While COVID-19… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events AZYO Aziyo Biologics $15.26 / -0.205 (-1.33%) 02/17/21 Aziyo Biologics announces first patient enrolled in HEAL study 11/16/20 Surgalign, Aziyo Biologics update distribution pact 09/28/20 Aziyo Biologics appoints Matthew Ferguson CFO AZYO Aziyo Biologics $15.26 / -0.205 (-1.33%) 11/19/20 Piper Sandler Aziyo Biologics posted 'nice revenue beat' in Q3, says Piper Sandler 11/02/20 Truist Aziyo Biologics initiated with a Buy at Truist 11/02/20 Truist Aziyo Biologics initiated with a Buy at Truist 11/02/20 Cowen Aziyo Biologics initiated with an Outperform at Cowen AZYO Aziyo Biologics $15.26 / -0.205 (-1.33%) 16:39 Today Aziyo Biologics reports Q4 EPS (57c), consensus (50c) 11/19/20 Aziyo Biologics reports Q3 EPS ($15.79), consensus ($3.42) 08 Oct AZYO Aziyo Biologics $15.26 / -0.205 (-1.33%) 10/11/20 Opening Day: iHuman makes trading debut amid U.S.-China tensions 03/02/21 41st Annual Healthcare Virtual Conference 16:30 Today Aziyo Biologics - AZYO 03/17/21 Aziyo Biologics 03/18/21 Aziyo Biologics
Earnings	Aziyo Biologics reports Q4 EPS (57c), consensus (50c) » 16:39 03/01/21 03/01 16:39 03/01/21 16:39 AZYO Aziyo Biologics $15.26 / -0.205 (-1.33%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events AZYO Aziyo Biologics $15.26 / -0.205 (-1.33%) 02/17/21 Aziyo Biologics announces first patient enrolled in HEAL study 11/16/20 Surgalign, Aziyo Biologics update distribution pact 09/28/20 Aziyo Biologics appoints Matthew Ferguson CFO AZYO Aziyo Biologics $15.26 / -0.205 (-1.33%) 11/19/20 Piper Sandler Aziyo Biologics posted 'nice revenue beat' in Q3, says Piper Sandler 11/02/20 Truist Aziyo Biologics initiated with a Buy at Truist 11/02/20 Truist Aziyo Biologics initiated with a Buy at Truist 11/02/20 Cowen Aziyo Biologics initiated with an Outperform at Cowen AZYO Aziyo Biologics $15.26 / -0.205 (-1.33%) 11/19/20 Aziyo Biologics reports Q3 EPS ($15.79), consensus ($3.42) 08 Oct AZYO Aziyo Biologics $15.26 / -0.205 (-1.33%) 10/11/20 Opening Day: iHuman makes trading debut amid U.S.-China tensions 03/02/21 41st Annual Healthcare Virtual Conference 16:30 Today Aziyo Biologics - AZYO 03/17/21 Aziyo Biologics 03/18/21 Aziyo Biologics
Syndicate	Editas Medicine files automatic mixed securities shelf 16:39 03/01/21 03/01 16:39 03/01/21 16:39 EDIT Editas Medicine $46.91 / +3.08 (+7.03%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options EDIT Editas Medicine $46.91 / +3.08 (+7.03%) 02/08/21 Editas Medicine appoints James Mullen as CEO 01/11/21 Editas Medicine Chief Scientific Officer Charles Albright, Ph.D to step down 01/11/21 Editas Medicine says FDA clears initiation of EDIT-301 clinical trial 12/21/20 Editas leads gene editing stocks higher with 46% rally to $95.42 EDIT Editas Medicine $46.91 / +3.08 (+7.03%) 06:26 Today Barclays Editas Medicine downgraded to Equal Weight from Overweight at Barclays 02/26/21 Truist Editas Medicine downgraded to Hold from Buy at Truist 02/26/21 Truist Editas Medicine downgraded to Hold from Buy at Truist 02/25/21 JPMorgan JPMorgan cuts Editas Medicine to Underweight after 'uneventful' Q4 update EDIT Editas Medicine $46.91 / +3.08 (+7.03%) 02/25/21 Editas Medicine reports Q4 EPS ($1.00), consensus (74c) 11/05/20 Editas Medicine reports Q3 EPS 12c, consensus (64c) 21 Jan 24 Jun EDIT Editas Medicine $46.91 / +3.08 (+7.03%) 01/11/21 Fly Intel: Wall Street's top stories for Monday 01/11/21 Fly Intel: Wall Street's top stories at midday 12/10/20 Fly Intel: Pre-market Movers 12/09/20 Fly Intel: After-Hours Movers EDIT Editas Medicine $46.91 / +3.08 (+7.03%) 12/21/20 Editas Medicine call volume above normal and directionally bullish 12/17/20 Largest borrow rate increases among liquid names 12/14/20 Editas Medicine call volume above normal and directionally bullish 10/30/20 Largest borrow rate increases among liquid names
Earnings	Gaia reports Q4 EPS 2c, consensus 0c » 16:39 03/01/21 03/01 16:39 03/01/21 16:39 GAIA Gaia $10.53 / +0.795 (+8.17%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events GAIA Gaia $10.53 / +0.795 (+8.17%) 09/09/20 Gaia says 'on track' for 30,000 net member additions in Q3 09/09/20 Gaia closes on sale of part of corporate HQ, reduces debt by $13M GAIA Gaia $10.53 / +0.795 (+8.17%) 11/10/20 Lake Street Gaia price target raised to $18 from $15 at Lake Street 06/10/20 B. Riley FBR Gaia can re-rate meaningfully over next year, says B. Riley FBR 05/15/20 B. Riley FBR Gaia shares offer 'significant re-rating' potential, says B. Riley FBR 04/28/20 Lake Street Gaia Q1 in line when excluding live events, says Lake Street GAIA Gaia $10.53 / +0.795 (+8.17%) 11/09/20 Gaia reports Q3 ex-items EPS 1c, consensus (4c) 03/15/21 33rd Annual Roth Virtual Conference 16:30 Today Gaia - GAIA

Earnings	C3.ai reports Q3 EPS (13c), consensus (16c) » 16:39 03/01/21 03/01 16:39 03/01/21 16:39 AI C3.ai $120.78 / +8.41 (+7.48%) Reports Q3 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options AI C3.ai $120.78 / +8.41 (+7.48%) 02/25/21 C3.ai awarded omnibus U.S. patent for end-to-end enterprise AI platform 02/01/21 Shell, C3, Baker Hughes, Microsoft launch Open AI Energy Initiative 12/31/20 C3.ai falls -5.9% 12/30/20 C3.ai rises 5.6% AI C3.ai $120.78 / +8.41 (+7.48%) 01/04/21 KeyBanc C3.ai initiated with a Sector Weight at KeyBanc 01/04/21 Wedbush Wedbush bullish on C3.ai, initiates with an Outperform 01/04/21 Canaccord C3.ai initiated with a Hold at Canaccord 01/04/21 Morgan Stanley C3.ai initiated with an Underweight at Morgan Stanley AI C3.ai $120.78 / +8.41 (+7.48%) 02/16/21 Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet 09 Dec AI C3.ai $120.78 / +8.41 (+7.48%) 01/04/21 Fly Intel: Pre-market Movers 12/13/20 Opening Day: Airbnb shares double in IPO, DoorDash soars in debut 09/23/20 Fly Intel: After-Hours Movers 00:00 Today Technology Virtual Conference 2021 17:00 Today C3.ai - AI AI C3.ai $120.78 / +8.41 (+7.48%) 02/09/21 C3 AI call volume above normal and directionally bullish 02/02/21 C3 AI call volume above normal and directionally bullish 01/06/21 Largest borrow rate increases among liquid names 12/15/20 Two new option listings on December 15th
Syndicate	WillScot announces offering of 10.75M shares of common stock for holders » 16:39 03/01/21 03/01 16:39 03/01/21 16:39 WSC WillScot Mobile Mini $27.76 / +0.05 (+0.18%) WillScot Mobile Mini… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Events WSC WillScot Mobile Mini $27.76 / +0.05 (+0.18%) 02/16/21 Cooperman's Omega Advisors buys GM, exits Lee in Q4 WSC WillScot Mobile Mini $27.76 / +0.05 (+0.18%) 02/02/21 Deutsche Bank WillScot Mobile Mini price target raised to $26 from $22 at Deutsche Bank 01/26/21 DA Davidson WillScot Mobile Mini price target raised to $30 from $25 at DA Davidson 01/13/21 Oppenheimer WillScot Mobile Mini price target raised to $29 from $24 at Oppenheimer 11/10/20 Barclays WillScot Mobile Mini reinstated with an Equal Weight at Barclays WSC WillScot Mobile Mini $27.76 / +0.05 (+0.18%) 02/25/21 WillScot Mobile Mini sees FY21 revenue $1.7B-$1.8B, consensus $1.71B 02/25/21 WillScot Mobile Mini reports Q4 revenue $437.65M, consensus $421.14M 11/05/20 WillScot Mobile Mini sees FY20 revenue $1.32B-$1.37B, down from $1.32B-$.42B 11/05/20 WillScot Mobile Mini reports Q3 EPS 7c, consensus 7c WSC WillScot Mobile Mini $27.76 / +0.05 (+0.18%) 10/21/20 WillScot Mobile Mini pitched as long idea by Dendur's Mac Levine 05/18/21 WillScot Mobile Mini
Conference/Events	UBS pulp & paper analyst to hold analyst/industry conference call » 16:38 03/01/21 03/01 16:38 03/01/21 16:38 Basic Materials Analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Downgrade	JPMorgan downgrades Athenex on 'huge surprise' from FDA » 16:38 03/01/21 03/01 16:38 03/01/21 16:38 ATNX Athenex $5.47 / -6.715 (-55.11%) JPMorgan analyst Ling… JPMorgan analyst Ling Wang downgraded Athenex to Neutral from Overweight with a price target of $7, down from $30. The stock closed Monday down 55%, or $6.64, to $5.46. The Complete Response Letter from the FDA in relation to the Oraxol filing in metastatic breast Cancer is a "huge surprise," Wang tells investors in a research note. The analyst is "very puzzled and disappointed" with the outcome and awaits further clarity upon management's meeting with the FDA. The setback opens up downside risk in the shares "due to a lack of clear near-term key value driver," says Wang. The analyst is concerned that the stock move may not wait till there is "full visibility." ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events ATNX Athenex $5.47 / -6.715 (-55.11%) 07:35 Today Athenex trading resumes 07:22 Today Athenex expects cash to fund operations into 2Q22 07:21 Today Athenex announces key anticipated future milestones 07:08 Today FDA requests new study from Athenex for oral paclitaxel plus encequidar ATNX Athenex $5.47 / -6.715 (-55.11%) 16:31 Today SVB Leerink Athenex downgraded to Market Perform from Outperform at SVB Leerink 16:27 Today JPMorgan Athenex downgraded to Neutral from Overweight at JPMorgan 13:53 Today Laidlaw Athenex price target lowered to $13 from $38 at Laidlaw 13:48 Today Needham Athenex downgraded to Hold from Buy at Needham ATNX Athenex $5.47 / -6.715 (-55.11%) 07:21 Today Athenex reports Q4 adjusted EPS (43c), consensus (44c) 11/05/20 Athenex sees 2020 y-o-y product sales growth in low twenties percentage growth 11/05/20 Athenex reports Q3 EPS (44c), consensus (43c) 10 Sep ATNX Athenex $5.47 / -6.715 (-55.11%) 12:23 Today Fly Intel: Wall Street's top stories at midday 09:15 Today Fly Intel: Pre-market Movers 12/15/20 Fly Intel: Pre-market Movers 09/21/20 Fly Insider: Kingsway Financial, Nvidia among week's notable insider trades 08:00 Today Athenex - ATNX
Hot Stocks	UFP Industries unit UBEECO buys Australia's Gilmores » 16:37 03/01/21 03/01 16:37 03/01/21 16:37 UFPI UFP Industries $63.04 / +1.955 (+3.20%) UFP Industries announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings UFPI UFP Industries $63.04 / +1.955 (+3.20%) 02/22/21 UFP Industries unit buys Spartanburg Forest Products assets for $17M 02/01/21 UFP Industries increases quarterly dividend 20% to 15c per share 01/04/21 UFP Industries gets initial payment from sale of interest in PalletOne 12/10/20 Equus II Inc announces pending sale of PalletOne equity for $232M UFPI UFP Industries $63.04 / +1.955 (+3.20%) 02/25/21 DA Davidson UFP Industries price target raised to $75 from $67 at DA Davidson 10/26/20 Benchmark UFP Industries price target raised to $74, named Top Pick at Benchmark 07/27/20 BMO Capital UFP Industries price target raised to $53 from $44 at BMO Capital 06/18/20 Benchmark UFP Industries price target raised to $56 from $50 at Benchmark UFPI UFP Industries $63.04 / +1.955 (+3.20%) 02/24/21 UFP Industries reports Q4 EPS $1.02, consensus 73c 10/21/20 UFP Industries reports Q3 EPS $1.25, consensus 89c

Events

Earnings calls, analyst events, roadshows and more

SCPL
Today at 17:30

SciPlay - SCPL Conference Calls
Today at 19:00

Financial Services Industry Meetings
NIO
Today at 20:00

NIO - NIO Conference Calls
KMPH
Tomorrow at 00:00

PDUFA Date for KP415 Government Event
UEPS
Tomorrow at 00:00

Net 1 UEPS - UEPS Conference Calls
AOSL
Tomorrow at 00:00

Alpha & Omega - AOSL Conference Calls
Tomorrow at 00:00

European Medtech & Services Virtual Conference Conferences

Virtual Conference
MFG ...
Tomorrow at 00:00

2021 Annual Washington Virtual Conference Conferences

Virtual Conference
Tomorrow at 00:00

Energy & Power Virtual Conference Conferences

Virtual Conference
SAIL ...
Tomorrow at 00:00

Technology, Media & Telecom Virtual Conference Conferences

Virtual Conference

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	VRT X VRT Vertiv Holdings Block Trade Managers: JPMorgan Priced at: $20.70 17.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYNH X SYNH Syneos Health Secondary Managers: Goldman Sachs Priced at: $74.95 7M Shares RCL X RCL Royal Caribbean Spot Secondary Managers: Morgan Stanley Priced at: $91.00 16.938M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan $124.96 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan & Morgan Stanley $166.50-169.95 1.5M Shares HLNE X HLNE Hamilton Lane Spot Secondary Managers: JPMorgan $88.25-89.25 1.45M Shares
Tues	GROY X GROY Gold Royalty IPO Managers: H.C. Wainwright & BMO Capital, CIBC, HAYW, Raymond James, Roth Capital, Scotiabank, Sprott, TD Securities $5.00 12M Shares OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB $32.00-34.00 31M Shares CDLX X CDLX Cardlytics Secondary Managers: Wells Fargo, Raymond James $141.28 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HSKA X HSKA Heska Secondary Managers: JPMorgan & Piper Sandler $201.39 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans $17.00-19.00 16.667M Shares AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC $27.97 2.5M Shares
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

CNH Industrial names Scott W. Wine CEO

TODAY'S FREE FLY STORIES

Get Full Fly Access